Live Breaking News & Updates on A siemens healthineers company

Stay updated with breaking news from A siemens healthineers company. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

University Hospitals Cleveland, Siemens Healthineers in New Alliance to Improve Oncology, Cardiovascular and Neurovascular Care for Patients

University Hospitals Cleveland, Siemens Healthineers in New Alliance to Improve Oncology, Cardiovascular and Neurovascular Care for Patients
itnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itnonline.com Daily Mail and Mail on Sunday newspapers.

Ohio , United-states , Case-western-reserve-university , Cleveland , Paul-hinchey , David-pacitti , Siemens-healthineers , Solutions-inc , Uh-seidman-cancer-center , A-siemens-healthineers-company , University-hospitals , Uh-harrington-heart-vascular-institute

Blue Earth Diagnostics Announces Agreement with Siemens Healthineers to Share PET Imaging Agent POSLUMA (Flotufolastat F 18) Clinical Data to Support AI-based Algorithms Development

Blue Earth Diagnostics Announces Agreement with Siemens Healthineers to Share PET Imaging Agent POSLUMA (Flotufolastat F 18) Clinical Data to Support AI-based Algorithms Development
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Munich , Bayern , Germany , Milan , Lombardia , Italy , United-kingdom , United-states , Mike-beyer , Bruce-spottiswoode , Scintomics-gmb , David-gauden

Blue Earth Diagnostics Announces Agreement with Siemens Healthineers to Share PET Imaging Agent POSLUMA® (Flotufolastat F 18) Clinical Data to Support AI-based Algorithms Development

Blue Earth Diagnostics Announces Agreement with Siemens Healthineers to Share PET Imaging Agent POSLUMA® (Flotufolastat F 18) Clinical Data to Support AI-based Algorithms Development
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Germany , Munich , Bayern , United-states , Milan , Lombardia , Italy , Siemens-healthineers , Scintomics-gmb , David-gauden , Bruce-spottiswoode , Technical-university-of-munich

Blue Earth Diagnostics Highlights Clinical Utility of POSLUMA (Flotufolastat F 18) PET and Post-scan Changes in Management in Patients with Suspected Recurrence of Prostate Cancer at ASCO GU

Blue Earth Diagnostics Highlights Clinical Utility of POSLUMA (Flotufolastat F 18) PET and Post-scan Changes in Management in Patients with Suspected Recurrence of Prostate Cancer at ASCO GU
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Italy , Germany , United-kingdom , Munich , Bayern , Milan , Lombardia , Clare-gidley , Santa-monica , Davide-gauden , Stefan-klotter , Priscilla-harlan

Blue Earth Diagnostics Highlights Clinical Utility of POSLUMA® (Flotufolastat F 18) PET and Post-scan Changes in Management in Patients with Suspected Recurrence of Prostate Cancer at ASCO GU

Blue Earth Diagnostics Highlights Clinical Utility of POSLUMA® (Flotufolastat F 18) PET and Post-scan Changes in Management in Patients with Suspected Recurrence of Prostate Cancer at ASCO GU
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Munich , Bayern , Germany , Italy , Milan , Lombardia , Santa-monica , Scintomics-gmb , Przemyslaw-twardowski , Davide-gauden , Study-group , Drug-administration

Additional Results of POSLUMA (Flotufolastat F 18) Performance in Newly Diagnosed, High-risk Prostate Cancer Patients Presented at ASTRO

Sub-group analysis from Blue Earth Diagnostics’ Phase 3 LIGHTHOUSE trial highlights POSLUMA utility to guide treatment selection and potentially avoid futile surgery

Germany , Munich , Bayern , Davide-gauden , Garya-ulaner , Scintomics-gmb , Philliph-kuo , Los-angeles , University-of-arizona , Study-group , Drug-administration , University-of-southern-california

New Data on POSLUMA® (Flotufolastat F 18) in Patients with Suspected Biochemical Recurrence of Prostate Cancer and Low-Very Low Prostate Specific Antigen (PSA) Levels Presented at ASTRO

New Data on POSLUMA® (Flotufolastat F 18) in Patients with Suspected Biochemical Recurrence of Prostate Cancer and Low-Very Low Prostate Specific Antigen (PSA) Levels Presented at ASTRO
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Munich , Bayern , Germany , Italy , United-kingdom , Milan , Lombardia , Clare-gidley , Mike-beyer , Davide-gauden , Scintomics-gmb , Asheshb-jani

Additional Results of POSLUMA® (Flotufolastat F 18) Performance in Newly Diagnosed, High-risk Prostate Cancer Patients Presented at ASTRO

Additional Results of POSLUMA® (Flotufolastat F 18) Performance in Newly Diagnosed, High-risk Prostate Cancer Patients Presented at ASTRO
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , Italy , Munich , Bayern , Germany , Milan , Lombardia , Davide-gauden , Garya-ulaner , Clare-gidley , Priscilla-harlan , Philliph-kuo

Blue Earth Diagnostics: Additional Results of POSLUMA (Flotufolastat F 18) Performance in Newly Diagnosed, High-risk Prostate Cancer Patients Presented at ASTRO

Blue Earth Diagnostics: Additional Results of POSLUMA (Flotufolastat F 18) Performance in Newly Diagnosed, High-risk Prostate Cancer Patients Presented at ASTRO
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Milan , Lombardia , Italy , Germany , Munich , Bayern , United-kingdom , Davide-gauden , Mike-beyer , Garya-ulaner , Priscilla-harlan , Scintomics-gmb

U.S. FDA Approves Blue Earth Diagnostics' POSLUMA (Flotufolastat F 18) Injection, First Radiohybrid PSMA-targeted PET Imaging Agent for Prostate Cancer

POSLUMA will be commercially available in the United States in early June 2023

Munich , Bayern , Germany , United-states , Texas , Scintomics-gmb , Davidm-schuster , Shelby-moneer , Davide-gauden , Brianf-chapin , Winship-cancer-institute-of-emory-university , Emory-university-school-of-medicine